AMAG Pharmaceuticals, Inc.

NASDAQ: AMAG
$5.97
-$0.20 (-3.2%)
Real time price as of March 31, 2020 1:34 pm EDT
Wednesday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Apple, Biomarin, Corning, Electronic Arts, FireEye, Grubhub, Nordstrom, NXP Semiconductors, Shopify and...
Jon C. Ogg
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Thursday included Allstate, Corning, DexCom, Lam Research, On Deck, Qualcomm, Spotify, Western Digital and Whiting Petroleum.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
Lee Jackson
The top analyst upgrades, downgrades and initiations seen on Tuesday included AbbVie, AMAG Pharmaceuticals, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora Media and Square.
Jon C. Ogg
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Campbell Soup, Ceridien HCM, Dillard's, Energizer, nLIGHT, Snap, Turtle Beach
Jon C. Ogg
The top analyst upgrades, downgrades and other research calls from Monday include AMAG Pharmaceuticals, Foot Locker, Groupon, H&R Block, McDonald's, Teradata, Under Armour and Valeant...
Jon C. Ogg
AMAG Pharmaceuticals saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Thursday include AMAG Pharmaceuticals, Baidu, Cisco, General Electric, Honeywell, 3M, Salesforce.com, SunPower and United...
Jon C. Ogg
Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.
Chris Lange
AMAG Pharmaceuticals shares took a sharp turn down after the company reported top-line results from its most recent pharmacokinetic study.
Chris Lange
The top analyst upgrades, downgrades and initiations on Tuesday include American Express, Goldman Sachs, Illumina, PayPal, Trivago and Williams Companies.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Abercrombie & Fitch, Altria, Anthem, United Continental, Blackstone and AMAG Pharmaceuticals.
Jon C. Ogg
Jefferies has four top biotech picks for 2016 that all have substantial upside and may provide investors with solid alpha for 2016.
Lee Jackson